News > No proof of Covaxin’s efficacy against Omicron strain in Bharat Biotech’s study on booster dose
No proof of Covaxin’s efficacy against Omicron strain in Bharat Biotech’s study on booster dose
![](https://daisinformaticsassets.s3.ap-south-1.amazonaws.com/1641697895.jpg)
Scroll | 09/01/2022 09:00 AM | Click to read full article
Vaccine maker Bharat Biotech has not provided any data on the efficacy of the Covaxin jab against the Omicron variant of coronavirus in a study on its booster doses published on Saturday.
This is despite the fact that from Monday, a booster shot of Covaxin will be administered as a “precaution dose” to citizens over 60 years with co-morbidities who have received two doses of the vaccine earlier.